BOSTON, MA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)BAIM INSTITUTE FOR CLINICAL RESEARCH INC, founded in 2000, is a mid-sized nonprofit in the Medical Research sector that reported $19.0M in total revenue in fiscal year 2023. Revenue surged 40% from the prior year, signaling strong growth momentum. The organization ran a surplus of $5.0M, a strong 27% operating margin.
TO IMPROVE HEALTH AND QUALITY OF LIFE BY COLLABORATING WITH ACADEMIC AND INDUSTRY PARTNERS TO CONDUCT HIGH QUALITY CLINICAL RESEARCH IN A PROFESSIONALLY NURTURING AND WORLDCLASS ACADEMIC ENVIRONMENT.
CLINICAL TRIAL SERVICES - DESIGN AND COORDINATE CLINICAL TRIALS, MANAGE THE CONDUCT OF THE TRIALS AND PERFORM ANALYSIS OF THE CLINICAL TRIAL RESULTS FOR ACADEMIC, PUBLISHING AND FDA SUBMISSION AND...
CLINICAL TRIAL SERVICES - DESIGN AND COORDINATE CLINICAL TRIALS, MANAGE THE CONDUCT OF THE TRIALS AND PERFORM ANALYSIS OF THE CLINICAL TRIAL RESULTS FOR ACADEMIC, PUBLISHING AND FDA SUBMISSION AND REVIEW PURPOSES.
ACADEMIC SUPPORT - BAIM PROVIDES FINANCIAL SUPPORT FOR RESEARCHERS ASSOCIATED WITH VARIOUS ORGANIZATIONS, INCLUDING BETH ISRAEL DEACONESS MEDICAL CENTER, WHICH ALSO SERVES AS ONE OF BAIM'S MEMBERS...
ACADEMIC SUPPORT - BAIM PROVIDES FINANCIAL SUPPORT FOR RESEARCHERS ASSOCIATED WITH VARIOUS ORGANIZATIONS, INCLUDING BETH ISRAEL DEACONESS MEDICAL CENTER, WHICH ALSO SERVES AS ONE OF BAIM'S MEMBERS, BRIGHAM AND WOMEN'S HOSPITAL, MASSACHUSETTS GENERAL HOSPITAL, AND BOSTON UNIVERSITY, FOR DESIGNING AND CONDUCTING CLINICAL RESEARCH AND FOR TRAINING AND ACADEMIC ACTIVITIES.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $18,960,523 | $13,536,792 | +0.4% |
| Expenses | $13,924,148 | $13,305,828 | +0.0% |
| Net Income | $5,036,375 | $230,964 | +20.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| SZABO MD PHD HON GYONGYI | TTEE (EX-OFF); (CAO, BIDMC & BILH) | 1.00 |
Director
|
$0 | $89,291 | $1,102,496 |
| GIBSON MD MICHAEL | TRUSTEE (EX-OFFICIO) & PRESIDENT | 30.00 |
Officer
Director
|
$430,000 | $85,530 | $1,030,292 |
| ZEIDEL MD MARK L | TTEE (EX-O)/CHAIR; (CHIEF MED BIDMC) | 1.00 |
Officer
Director
|
$0 | $87,340 | $979,372 |
| GERSZTEN MD ROBERT | TTEE (EXOFF)(CHIEF,BIDMC CARDIO MED) | 1.00 |
Director
|
$0 | $42,355 | $721,623 |
| AGNEW MEGHAN | TTEE (EX OFFICIO) & TREAS; CFO, HFMP | 1.00 |
Officer
Director
|
$0 | $89,105 | $518,759 |
| MERSKI CARA | TTEE (EXOFF);BILH DEP COMPLIANCE OFF | 1.00 |
Director
|
$0 | $40,704 | $285,380 |
| COLOZZO MEGHAN | TTEE (EXO) (DIR, COMPL & PRIV, BILH) | 1.00 |
Director
|
$0 | $14,345 | $201,528 |
| ARMSTRONG ESQ EMILY | CLERK (EXO); DIV VP DEP GC BOS, BILH | 1.00 |
Officer
|
$0 | $41,550 | $351,216 |
| FRITZ SUE | SR. DIRECTOR, FINANCE | 55.00 |
Officer
|
$208,738 | $22,191 | $230,929 |
| HALPRIN VICTORIA | DIRECTOR, FINANCE | 55.00 |
Officer
|
$117,652 | $7,870 | $125,522 |
| FRIZZELL CHARLES | EVP, BUSINESS OPS (END 9/20/23) | 55.00 |
Key Emp
|
$286,526 | $11,131 | $297,657 |
| CHEN XIAOHUA | DIRECTOR OF BIOSTATS | 55.00 |
Key Emp
|
$240,194 | $9,600 | $249,794 |
| WEDGE PATRICIA | CHIEF OPERATING OFFICER | 55.00 |
Key Emp
|
$207,292 | $28,698 | $235,990 |
| PECJO BRIAN | DIRECTOR, INFORMATION TECHNOLOGY | 55.00 |
Key Emp
|
$176,805 | $22,574 | $199,379 |
| THUM CLAUDIA | DIRECTOR, PROJECT MANAGEMENT | 55.00 |
Highest
|
$160,698 | $25,585 | $186,283 |
| IVANOVA ALLA | DIRECTOR, DATA MANAGEMENT | 55.00 |
Highest
|
$146,762 | $33,073 | $179,835 |
| AMMU SONIA T | DIRECTOR, CLINICAL OPERATIONS | 55.00 |
Highest
|
$164,673 | $6,923 | $171,596 |
| SULLIVAN GAIL | DIRECTOR OF HUMAN RESOURCES | 55.00 |
Highest
|
$145,206 | $15,838 | $161,044 |
| THIIRAH KELLY | DIRECTOR, CONTRACTS | 55.00 |
Highest
|
$137,140 | $18,011 | $155,151 |
| FREEDMAN MD STEVEN | FRMR TTEE & CHAIR (PHYSICIAN, BIDMC) | 0.00 |
|
$0 | $64,211 | $600,162 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $18,960,523 | $13,924,148 | $30,238,751 | $5,036,375 |
| 2023 | $13,536,792 | $13,305,828 | $26,425,573 | $230,964 |
| 2022 | $14,165,368 | $12,404,724 | $20,688,470 | $1,760,644 |
| 2020 | $17,724,993 | $15,058,395 | $19,935,879 | $2,666,598 |
| 2019 | $17,860,063 | $15,190,589 | $15,548,353 | $2,669,474 |
| 2018 | $20,185,448 | $17,220,636 | $15,315,526 | $2,964,812 |
Compare BAIM INSTITUTE FOR CLINICAL RESEARCH INC with other nonprofits in Massachusetts and across the country.